13 completed, 2 unknown, 1 recruiting, 1 terminated. 17 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 13, Unknown 2, Recruiting 1, Terminated 1 |
Follow Tinea Pedis: new trials by email Literature Review of Tinea Pedis trials Research Report on Tinea Pedis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study 1% Tolnaftate Stick Formula A, 1% Tolnaftate Stick Formula B, 1% Tolnaftate Stick Formula C - Tinea Pedis | Phase 2 | Recruiting | Propedix, Inc. | 150 | 2024-12-30 | 2025-11-28 |
| A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis DBI-001 Gel, DBI-002 Gel, Aqueous Gel - Tinea Pedis | Phase 2 | Unknown | DermBiont, Inc. | 24 | 2022-09-08 | 2023-02-14 |
| A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis UHE-103A1 cream, UHE-103A2 cream, UHE-103B cream - Tinea Pedis | Phase 2 | Completed | Therapeutics, Inc. | 240 | 2019-03-15 | 2021-10-28 |
| A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis Janthinobacterium lividum - Tinea Pedis | Phase 2 | Completed | DermBiont, Inc. | 12 | 2019-02-19 | 2025-06-17 |
| SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS TERBINAFINE HYDROCHLORIDE (1%), BUTENAFINE HYDROCHLORIDE (1%), Vehicle Control - Tinea Pedis | Phase 2 | Unknown | United Laboratories | 42 | 2019-01-02 | 2019-06-26 |
| Three-Arm Trial of Novel Treatment for Tinea Pedis Experimental Drug SESC 01, Placebo, Terbinafine Hydrochloride - Tinea Pedis | Phase 2 | Completed | South End Skin Care | 90 | 2017-01-03 | 2017-10-06 |
| Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis S2G6T-1, S2G6T-2, S2G6T-3 - Tinea Pedis | Phase 2 | Terminated | Sol-Gel Technologies, Ltd. | 283 | 2016-09-01 | 2020-11-18 |
| Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot Nitric Oxide, Water - Tinea Pedis | Phase 2 | Completed | Nitric Solutions Inc. | 20 | 2016-08-13 | 2019-09-20 |
| SB208 for the Treatment of Tinea Pedis SB208 2%, SB208 4%, SB208 16% - Tinea Pedis | Phase 2 | Completed | Novan, Inc. | 222 | 2016-07-19 | 2019-01-10 |
| Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis Dapaconazole, Ketoconazole - Tinea Pedis | Phase 2 | Completed | Gilberto De Nucci | 60 | 2014-07-01 | 2016-07-07 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis VT-1161, placebo - Tinea Pedis | Phase 2 | Completed | Viamet | 50 | 2013-08-01 | 2018-08-01 |
| Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai kandhaga rasayanam - Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied | Phase 2 | Completed | National institute of Siddha | 50 | 2012-06-01 | 2014-09-12 |
| Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis LAS41003, LAS189961, LAS189962 - Tinea Pedis | Phase 2 | Completed | Almirall, S.A. | 120 | 2010-02-01 | 2012-07-09 |
| Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo Bifonazole spray once daily, Bifonazole spray twice daily, Placebo - Tinea Pedis | Phase 2 | Completed | Bayer | 220 | 2009-12-01 | 2015-01-27 |
| A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis 1% gaseous Nitric Oxide blended in Oxygen - Tinea Pedis | Phase 2 | Completed | Nitric BioTherapeutics, Inc | 92 | 2009-06-01 | 2012-10-22 |
| Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot) Luliconazole Cream 1% - 2 wks, Placebo Comparator -2 wks, Luliconazole Cream 1% - 4 wks - Tinea Pedis | Phase 2 | Completed | Tinea Pharmaceuticals | 147 | 2009-03-01 | 2011-06-21 |
| A Study of Econazole Foam 1% in Athlete's Foot Econazole Nitrate Cream 1%, Econazole Nitrate Foam 1%, Vehicle Foam - Tinea Pedis, Athlete's Foot | Phase 2 | Completed | AmDerma | 135 | 2008-03-01 | 2013-01-09 |
Communicable Diseases (1) · Dermatomycoses (1) · Foot Dermatoses (1) · Foot Diseases (1) · Infections (1) · Mycoses (1) · Pruritus (1) · Skin Diseases (1) · Tinea (1) · Tinea Cruris (1) · tinea barbae (1)
Bacterial Infections and Mycoses (17) · Pathological Conditions, Signs and Symptoms (17) · Signs and Symptoms (17) · Skin Diseases, Infectious (17) · Skin Manifestations (17) · Skin and Connective Tissue Diseases (17) · Dermatomycoses (16) · Foot Dermatoses (16) · Foot Diseases (16) · Infections (16) · Mycoses (16) · Pruritus (16) · Skin Diseases (16) · Tinea (16) · Dermatitis (1)
Terbinafine (2) · 1-(2-(2,4-dichlorophenyl)-2-(4-(trifluoromethyl)benzyloxy)ethyl)-1H-imidazole (1) · BANG polymer gel (1) · Ketoconazole (1) · Nitric Oxide (1) · Oxygen (1) · VT-1161 (1) · Water (1) · butenafine (1) · octenidine (1)
DermBiont, Inc. (2) · Almirall, S.A. (1) · AmDerma (1) · Bayer (1) · Gilberto De Nucci (1) · National institute of Siddha (1) · Nitric BioTherapeutics, Inc (1) · Nitric Solutions Inc. (1) · Novan, Inc. (1) · Propedix, Inc. (1) · Sol-Gel Technologies, Ltd. (1) · South End Skin Care (1) · Therapeutics, Inc. (1) · Tinea Pharmaceuticals (1) · United Laboratories (1)
United States (8) · Canada (2) · Dominican Republic (2) · Germany (2) · India (1) · Philippines (1) · Puerto Rico (1) · Saint Kitts and Nevis (1)
Carl Schanbacher, MD (1) · Christoph Willers, MD, MBA (1) · Emma Taylor, Ph.D (1) · Gilberto De Nucci, PhD (1) · Kathleen O Ashenfelter, MS (1) · Lisa Miller, M.D. (1) · M Joyce Rico, MD (1) · Marietta Radona, MD (1)
2008 (1), 2009 (1)